Journals / Ulusal Cerrahi Dergisi / 2015 / Cilt: 31 - Sayı: 2

Factors affecting survival in patients who underwent pancreaticoduodenectomy for periampullary cancers

Periampuller bölge malign tümörleri nedeniyle pankreatikoduodenektomi uygulanan hastalarda mortalite ve yaşam süresi üzerine etki eden faktörler

Pages
72–77
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These factors could help us to estimate survival rates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The purpose of this study was to determine the factors affecting survival in patients who underwent pancreaticoduodenectomy for periampullary cancers and to discuss the outcomes of our findings.
📊
Key Findings & Data:Material and Methods: This retrospective study included 79 patients who underwent pancreaticoduodenectomy for periampullary cancers between September 1987 and October 2011 in the Department of General Surgery at Ondokuz Mayis University School of Medicine.
💡
Conclusion & Impact:These factors could help us to estimate survival rates.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The purpose of this study was to determine the factors affecting survival in patients who underwent pancreaticoduodenectomy for periampullary cancers and to discuss the outcomes of our findings. Material and Methods: This retrospective study included 79 patients who underwent pancreaticoduodenectomy for periampullary cancers between September 1987 and October 2011 in the Department of General Surgery at Ondokuz Mayis University School of Medicine. The factors of age, tumor localization, tumor size, lymphovascular invasion, status of lymph node metastasis, tumor differentiation, preoperative CA 19-9 levels, preoperative total bilirubin levels, preoperative albumin levels, and preoperative biliary drainage were investigated to determine their influence on survival. The survival periods were calculated using the Kaplan-Meier method. The log-rank test was used for comparison of the prognostic factors. The independent prognostic factors affecting survival were determined by Cox hazard regression analysis and hazard ratios (HR) and 95% confidence intervals (CI) were calculated. P<0.05 was considered as significant. Results: The following were identified as independent prognostic factors adversely affecting survival: tumor size >=2 cm (HR: 2.0, 95% CI: 0.27-0.90), lymphovascular invasion (HR: 2.9, 95% CI: 0.18-0.60), CA 19-9 levels >=100 U/mL (HR: 2.0, 95% CI: 0.26-0.90), and albumin levels <2.5 mg/dL (HR: 2.7, 95% CI: 1.14-6.66). Conclusion: The independent prognostic factors identified in this study can be used for selection of patients for whom pancreaticoduodenectomy should be applied for periampullary cancers. These factors could help us to estimate survival rates.

Özet

Amaç: Periampuller bölge kanserleri nedeniyle pankreatikoduodenektomi uygulanan hastalarda mortalite ve sağkalıma etki eden faktörleri saptamak ve pankreatikoduodenektomi serimizin sonuçlarını tartışmaktır.Gereç ve Yöntemler: Ondokuz Mayıs Üniversitesi Tıp Fakültesi Genel Cerrahi Kliniği'nde, Eylül 1987 ve Ekim 2011 tarihleri arasında periampuller bölge kanserleri nedeniyle pankreatikoduodenektomi yapılan 79 hasta çalışmaya alındı. Bu retrospektif çalışmada yaş, tümör lokalizasyonu, tümör boyutu, lenfovasküler invazyon, lenf nodu metastazı, tümörün diferansiyasyon durumu, preoperatif CA 19-9 düzeyi, preoperatif total bilirubin düzeyi, preoperatif albumin düzeyi, preoperatif safra drenaj girişimi sağkalıma etkisi araştırılacak faktörler olarak belirlendi. Sağkalım süreleri Kaplan-Meier yöntemi ile hesaplandı. Prognostik faktörlerin karşılaştırılması log-rank testi kullanılarak yapıldı ve sağkalımı etkileyen bağımsız prognostik faktörler Cox hazard regresyon testi ile belirlendi, risk oranları (RO) ve %95 güven aralıkları (GA) hesaplandı. P =2 cm olması (RO 2,0, %95 GA: 0,27-0,90), lenfovasküler invazyon (RO 2,9, %95 GA: 0,18-0,60), CA 19-9 >=100 U/mL olması (RO 2,0, %95 GA: 0,26-0,90) ve albumin düzeyinin <2,5 mg/dL olması (RO 2,7, %95 GA: 1,14-6,66) sağkalımı olumsuz etkileyen bağımsız prognostik faktörler olarak saptandı.Sonuç: Bağımsız prognostik faktörleri periampuller kanser nedeniyle pankreatikoduodenektomi uygulanacak uygun hastaların seçiminde ve bu hastaların postoperatif sağkalımını öngörmekte kullanabiliriz

🔖

Cite This Article

ŞEREN, T. D., TOPGÜL, K., KOCA, B., ERZURUMLU, K. (2015). Factors affecting survival in patients who underwent pancreaticoduodenectomy for periampullary cancers. Ulusal Cerrahi Dergisi, Cilt: 31 - Sayı: 2, 72–77. https://ajindex.com/articles/325646

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Noor MT, Vaiphei K, Nagi B, Singh K, Kochnar R. Role of needle knife assisted ampullary biopsy in the diagnosis of periampullary carci- noma. World J Gastrointest Endosc 2011; 3: 220-224. [CrossRef] Kim K, Chie EK, Jang JY, Kim SW, Han SW, Oh DY, et al. Prognostic significance of tumour location after adjuvant chemoradiothe- rapy for periampullary adenocarcinoma. ClinTransl Oncol 2012; 14: 391-395. [CrossRef] Kim CG, Jo S, Kim JS. Impact of surgical volume on nation wide hospital mortality after pancreaticoduodenectomy. World J Gast- roenterol 2012; 18: 4175-4181. [CrossRef] Beger HG, Treitschke F, Gansauge F, Harada N, Hiki N, Mattfeldt T. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg 1999; 134: 526-532. [CrossRef] Beger HG, Rau B, Gansauge F, Poch B, Link KH. Treatment of panc- reatic cancer: Challenge of the facts. World J Surg 2003; 27: 1075- 1084. [CrossRef] Jarufe NP, Coldham C, Mayer AD, Mirza DF, Buckels JA, Bramhall SR. Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region. Dig Surg 2004; 21: 202-209. [CrossRef] Johnson CD, Ozmen MM. Pankreas kanseri. In. Temel Cerrahi. Sayek İ (ed). Ucuncu baskı. Ankara: Guneş Kitabevi. 2004: 1429- 1436. Nuzzo G, Clemente G, Cadeddu F, Giovannini I. Palliation of unresectable periampullary neoplasms: "surgical" versus "non- surgical" approach. Hepatogastroenterology 2004; 51: 1282- 1285. Mersin HH, Yıldırım E, İrkin F, Berberoğlu U, Gülben K. Düşük yoğunluklu bir merkezde pankreatikoduodenektomi deneyimi. Ulus Cerrahi Derg 2010; 20: 18-23. Howard JM. Development and progress in resective surgery for pancreatic cancer. World J Surg 1999; 23: 901-906. [CrossRef] Crile G Jr. The advantages of bypass operations over radical panc- reatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 1970; 130: 1049-1053. Shapiro TM. Adenocarcinoma of the pancreas: a statistical analy- sis of biliary bypass vs Whipple resection in good risk patients. Ann Surg 1975; 182: 715-721. [CrossRef] Gudjonsson B. Cancer of the pancreas: 50 years of surgery. Can- cer 1987; 60: 2284-2303. [CrossRef] Monge JJ, Judd ES, Gage RP. Radical pancreaticoduodenectomy: a 22-year experience with complications, mortality rate and sur- vival rate. Ann Surg 1964; 160: 711-722.
  2. Lansing PB, Blalock JB, Ochsner JL. Pancreaticoduodenectomy: a retrospective review 1949-1969. Am Surg 1972; 38: